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Behavioural abnormalities such as impulse control disorders may develop when patients with Parkinson’s disease receive
dopaminergic therapy, although they can be controlled by deep brain stimulation of the subthalamic nucleus. We have recorded
local field potentials in the subthalamic nucleus of 28 patients with surgically implanted subthalamic electrodes. According to
the predominant clinical features of each patient, their Parkinson’s disease was associated with impulse control disorders
(n = 10), dyskinesias (n = 9) or no dopaminergic mediated motor or behavioural complications (n = 9). Recordings were obtained
during the OFF and ON dopaminergic states and the power spectrum of the subthalamic activity as well as the subthalamo-
cortical coherence were analysed using Fourier transform-based techniques. The position of each electrode contact was deter-
mined in the postoperative magnetic resonance image to define the topography of the oscillatory activity recorded in each
patient. In the OFF state, the three groups of patients had similar oscillatory activity. By contrast, in the ON state, the patients
with impulse control disorders displayed theta-alpha (4–10 Hz) activity (mean peak: 6.71 Hz) that was generated 2–8 mm below
the intercommissural line. Similarly, the patients with dyskinesia showed theta-alpha activity that peaked at a higher frequency
(mean: 8.38 Hz) and was generated 0–2 mm below the intercommissural line. No such activity was detected in patients that
displayed no dopaminergic side effects. Cortico-subthalamic coherence was more frequent in the impulsive patients in the
4–7.5 Hz range in scalp electrodes placed on the frontal regions anterior to the primary motor cortex, while in patients with
dyskinesia it was in the 7.5–10 Hz range in the leads overlying the primary motor and supplementary motor area. Thus,
dopaminergic side effects in Parkinson’s disease are associated with oscillatory activity in the theta-alpha band, but at different
frequencies and with different topography for the motor (dyskinesias) and behavioural (abnormal impulsivity) manifestations.
These findings suggest that the activity recorded in parkinsonian patients with impulse control disorders stems from the
associative-limbic area (ventral subthalamic area), which is coherent with premotor frontal cortical activity. Conversely, in
patients with L-dopa-induced dyskinesias such activity is recorded in the motor area (dorsal subthalamic area) and it is coherent
with cortical motor activity. Consequently, the subthalamic nucleus appears to be implicated in the motor and behavioural
complications associated with dopaminergic drugs in Parkinson’s disease, specifically engaging different anatomo-functional
territories.
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Introduction
The use of dopaminergic therapy for Parkinson’s disease is asso-
ciated with motor and behavioural side effects, of which
L-dopa-induced dyskinesias (LID) and psychiatric complications
are the most frequent and troublesome (Voon et al., 2009).
Psychiatric complications include impulse control disorders (ICD)
such as compulsive gambling, excessive shopping, increased
sexual and eating desire, stereotypic behaviours (typically punding
and hobbyism) and the dopamine dysregulation syndrome char-
acterized by addictive excessive dopaminergic therapy (Lawrence
et al., 2003; Bonvin et al., 2007). These may occur in isolation or
in different combinations causing severe disruption to the patient’s
family, social and emotional life. To improve these psychiatric
abnormalities requires a reduction in dopaminergic treatment, al-
though in practice this is limited by the worsening of the parkin-
sonian motor features. Deep brain stimulation of the subthalamic
nucleus provides an improvement of the OFF parkinsonian state,
allowing a significant reduction in the daily consumption of dopa-
minergic drugs (Rodriguez-Oroz et al., 2005; Deuschl et al.,
2006). Dyskinesias are also improved, mainly related to dose
reduction, and therefore as an indirect effect of surgery (Krack
et al., 1999; Vingerhoets et al., 2002; Russmann et al., 2004).
Similarly, some retrospective studies (Witjas et al., 2005; Bandini
et al., 2007; Knobel et al., 2008) and a recent prospective study
(Thobois et al., 2010) have revealed that ICD can be improved
after subthalamic nucleus deep brain stimulation provided a reduc-
tion of dopaminergic drugs is achieved. Negative results and
controversy in this regard are probably explained by instances
when patients remained on high doses of dopaminergic drugs
(Lim et al., 2009).
Subthalamic nucleus deep brain stimulation can also trigger
abnormal impulsivity in patients with Parkinson’s disease, such as
hypersexuality (Romito et al., 2002; Doshi and Bhargava, 2008),
manic behaviour or shopping (Krack et al., 2001; Kulisevsky et al.,
2002; Romito et al., 2002; Herzog et al., 2003; Mandat et al.,
2006; Mallet et al., 2007; Raucher-Chene et al., 2008) and
increased impulsivity (Witt et al., 2004; Frank et al., 2007;
Ballanger et al., 2009). Interestingly, in some patients with
Parkinson’s disease with ICD induced by subthalamic nucleus
deep brain stimulation, the abnormal behaviour was provoked
by stimulation with a ventral contact of the electrode and sup-
pressed by switching off this contact (Kulisevsky et al., 2002;
Mandat et al., 2006; Mallet et al., 2007; Raucher-Chene et al.,
2008). This abnormal behaviour was not observed when the active
contact was a more dorsal one, which is in a position compatible
with the motor region of the subthalamic nucleus (Rodriguez-Oroz
et al., 2001), while the greatest anti-parkinsonian benefits were
achieved (Lanotte et al., 2002; Starr et al., 2002). In two such
cases, the localization of the four contacts of the quadripolar
electrode was ascertained with an interactive brain atlas to show
that the hypomanic state was exclusively caused by stimulation
through a ventral contact in the anteromedial subthalamic nucleus
territory, which corresponds to the limbic area of the nucleus
(Parent and Hazrati, 1995; Mallet et al., 2007). These observations
suggest a role for the subthalamic nucleus in impulse control
and in the origin of impulsivity in patients with Parkinson’s disease,
as well as indicating an anatomo-functional division within the
subthalamic nucleus that may underlie different clinical manifest-
ations. Accordingly, the dorsal area would appear to be involved in
parkinsonian motor features and the medioventral in behavioural
aspects.
In patients with Parkinson’s disease, the oscillatory activity
of the subthalamic nucleus recorded through the electrodes
implanted for deep brain stimulation displays dopamine-dependent
changes whereby the OFF to ON motor state is signalled by a
marked reduction in beta band activity (Brown, 2003). In addition,
in patients with LID there is a peak at 4–10 Hz at the subthalamic
nucleus (Alonso-Frech et al., 2006). Here for the first time we
report an oscillatory theta-alpha activity in the ventral subthalamic
nucleus associated with ICD in patients with Parkinson’s disease.
This activity is distinct from that associated with LID and was also
coherent with EEG activity recorded in frontal areas.
Materials and methods
Patients
Patients with Parkinson’s disease, in whom electrodes for chronic
stimulation had been bilaterally implanted in the subthalamic nucleus
over the last five years, were studied. All patients fulfilled the UK
Parkinson’s Disease Society Brain Bank clinical diagnostic criteria
(Hughes et al., 1992). The patients were classified into three groups:
(i) patients with Parkinson’s disease with ICD (Parkinson’s disease-ICD)
as the main complication of dopaminergic treatment, who had a his-
tory of no or only mild dyskinesias and who did not exhibit dyskinesias
during the recording session; (ii) patients with Parkinson’s disease with
severe dyskinesias associated with chronic L-dopa treatment and no
ICD (Parkinson’s disease-LID), who had dyskinesias during the record-
ing session in the ON state, as assessed by a neurologist (M.A. or
M.C.R.) and (iii) patients with Parkinson’s disease free of ICD or
clinically relevant dyskinesias (Parkinson’s disease-controls), who
were offered surgery because of severe OFF episodes and gait freezing
and in whom dyskinesias did not occur during the recording session.
The diagnosis of ICD was suspected when there was a clearly recog-
nized history of behavioural disorders such as dopamine dysregulation
syndrome, punding, hobbyism, gambling, shopping or increased sexu-
ality or eating, which was directly related to dopaminergic treatment
for 46 months prior to the assessment for surgery. In the surgical
protocol, each patient was routinely asked about any abnormal
behaviour and a psychiatrist evaluated all patients while under treat-
ment with their usual medication prior to surgery. ICD was confirmed
when patients fulfilled the diagnostic criteria for organic or ‘functional’
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mood disorders (International Classification of Diseases-10). Following
such assessment, the administration of dopaminergic agonists was
reduced or stopped and selective serotonin reuptake inhibitors
and/or atypical antipsychotics were prescribed for 1–2 months in
order to improve the behavioural abnormalities prior to surgery.
Thus, ICD improved in most patients but remained present at the
time of surgery. The Parkinson’s disease Impulse-Compulsive
Questionnaire (Weintraub et al., 2009), which only became available
during the study, was completed retrospectively by each patient to
confirm the presence of ICD.
The global motor state was assessed preoperatively in all patients in
OFF and ON conditions using the motor section of the Unified
Parkinson’s Disease Rating Scale (UPDRS-III) and the LID status was
assessed with a specific dyskinesia scale (Langston et al., 1992; Goetz
et al., 1994). The L-dopa equivalent daily dose was calculated for each
patient as follows: L-dopa/day dose (mg) = L-dopa (mg) + [L-dopa
retard (mg) 0.77]. In the case of entacapone/tolcapone
co-administration, the L-dopa dose was multiplied by 1.33. For dopa-
minergic agonists, the formula used was [rotigotine (mg)5] + [ropi-
nirole (mg) 20] + [pramiprexole (mg) 67] + [cabergoline (mg)67]
+ [pergolide (mg)100] (Grosset et al., 2004).
A neuropsychological evaluation was administered preoperatively
during the ON state to ensure that patients were not cognitively
impaired (Rodriguez-Oroz et al., 2009). Depression was also rated
using the Yesavage Geriatric Depression Rating Scale (Yesavage
et al., 1982) to exclude patients with severe depression. The Ethics
Committee for Medical Research approved the study and all patients
provided their informed consent before entering the study. Three
patients, two in the Parkinson’s disease-LID group and one in the
Parkinson’s disease-control group, were included in a previous report
(Alonso-Frech et al., 2006).
Surgery
The procedure used was the one that has been routinely carried out by
our group for several years (Guridi et al., 2000; Rodriguez-Oroz et al.,
2001; see Supplementary material for details).
A Medtronic 3389 electrode with four active contacts (0, 1, 2 and 3
from ventral to dorsal and each 1.5 mm high at 0.5 mm intervals; total
length 7.5 mm) was placed at the selected coordinates in the subtha-
lamic nucleus with the most ventral contact (contact 0) placed in the
ventral part of the nucleus. The clinical assessment of the efficacy and
adverse effects of deep brain stimulation was performed intra-
operatively before securing the electrode in the chosen position. The
electrode was then fixed with a burr hole ring and cap and connected
to percutaneous connectors with extension wires that exited through
a small incision in the skin. The correct placement of the electrodes
was corroborated in all subjects by postoperative MRI. Chronic stimu-
lation (3.21  0.82 V, 70.2  16.5ms, 178.4  13.3 Hz) induced a
mean reduction of 69.8% (SD 16%) in the OFF UPDRS-III score in
the first year postoperatively, in general agreement with our own and
other groups results (Rodriguez-Oroz et al., 2000, 2004, 2005;
Ostergaard et al., 2002; Welter et al., 2002; Krack et al., 2003;
Tamma et al., 2003; Kleiner-Fisman et al., 2006). Regarding the evo-
lution of ICD, it was suppressed in six patients, improved in three and
unchanged in one (Table 2). Monopolar stimulation using a single
contact was applied in 33 nuclei (59% of the electrodes) and using
two contacts in seven nuclei (Supplementary Table 1). Thus, mono-
polar stimulation was applied in 40 out of 56 nuclei (71.5% of the
electrodes). Bipolar stimulation was used to avoid side effects, mainly
dysarthria (n= 4), capsular stimulation with contralateral facial contrac-
tion (n= 2) and dyskinesias (n= 5), or because a higher motor benefit
was encountered (n= 5). In addition, in three patients belonging to the
ICD group, stimulation through the ventral contact induced a euphoric
state, which reverted by switching off the stimulator. Stimulation
through the dorsal contacts was used to avoid such misbehaviour.
Recording procedure and data
acquisition
Signals were recorded 4–5 days after implantation of the electrodes in
the subthalamic nucleus and before internalizing the connector cables
and the implantable pulse generator. Subthalamic nucleus field poten-
tials were recorded by connecting the different leads of the wire
corresponding to each contact on the electrode to differential ampli-
fiers using a custom-made cable and a sequential bipolar montage,
giving a total of three channels per side (0–1, 1–2 and 2–3). In
15 patients studied prior to 2007, the subthalamic nucleus bipolar
signal was filtered at 0.3–100 Hz, amplified 50 000-fold (Digitimer
C-150, Welwyn Garden City, Hertfordshire, UK) and sampled at a
frequency of 200 Hz. In the other 13 patients, the signal was filtered
at 0.3–1000 Hz, amplified 50 000-fold and sampled at 2000 Hz. Five
EEG channels (C3, Cz, C4, F3 and F4, referenced to both ear lobes)
were obtained simultaneously. The C3, C4 and Cz electrodes overlie
the sensorimotor cortex, including the primary motor cortex (M1) and
the supplementary motor area, while the F3 and F4 electrodes
are placed in a more anterior position overlying the premotor cortex
but in close vicinity to the dorsolateral prefrontal cortex. The EEG
signal was filtered using similar settings to those used in the subtha-
lamic nucleus signals, amplified 20 000-fold (Brain Atlas amplifiers,
Bio-logic Systems, Mundelein, IL, USA), and sampled at 200 Hz
in 15 patients and at 2000 Hz in 13 patients. Both subthalamic
nucleus and EEG signals were stored on a PC using Spike2 software
and a CED 1401 plus A/D converter (Cambridge Electronic Design,
Cambridge, UK).
Patients were first studied in the OFF motor state after overnight
withdrawal of all anti-parkinsonian drugs (412 h). None of the patients
had severe or moderate rest tremor during the recording, probably due
to the impact effect that is frequently observed in the first days
after surgery. Subsequently, they were given the usual morning dose
of L-dopa (150–250 mg) and studied again after reaching the ON
motor state, as evaluated by a neurologist (M.A. or M.C.R.). The
patients were instructed to stay awake, relaxing with their eyes open
and to avoid voluntary movements during the initial 10 min of the re-
cording (in the OFF state), as well as during a 10 min period after reaching
the ON motor state. Signals were recorded continuously with Spike2
software during the rest periods. Two 5 min segments of OFF and ON
resting activity were selected offline for further analyses (see below).
Signal analysis
All analyses were performed using MATLAB 7.7 software (Mathworks,
Natick, MA, USA). Data corresponding to the 13 patients with a
sampling frequency of 2000 Hz were first low-pass filtered at 100 Hz
and subsequently down-sampled to match a common sampling rate
of 200 Hz.
Power spectrum analysis
Time-evolving power spectra of subthalamic nucleus and EEG channels
were estimated for all the patients in each motor state (OFF and ON),
using the fast Fourier transform with blocks of 1024 samples, a
Hanning window and a 75% overlap, until the whole recording was
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analysed. The transforms obtained offered a resolution of 0.2 Hz and
1 s. This makes it possible to obtain an estimation of the frequency
distribution and the temporal evolution of the oscillatory activity for
each patient in the OFF and ON motor states, hemispheres and re-
cording channels. Thus each recording was reviewed and segments of
activity recorded at rest over 300 s were selected for each patient in
the OFF and ON motor states. We estimated the Welch periodogram
(Halliday et al., 1995) using non-overlapping sections of 1024 points
and with a Hanning window, giving a resolution of 0.2 Hz per bin. In
these spectra, the mean power was measured in two different fre-
quency bands: theta-alpha (4–10 Hz) and beta (12–30 Hz) in the ON
and OFF motor states. With these values we calculated the relative
mean ON to OFF power ratio in each band (mean power ON/mean
power OFF). Relative power values were chosen instead of absolute
power values in order to reduce inter-subject variability and facilitate
the normalization of the data. We also measured the peak frequency
of the spectral peaks that appeared in the spectrum of the theta-alpha
range. We defined a peak when its power was42 SD over the base-
line spectrum.
Coherence analysis
We estimated the coherence between the different subthalamic nu-
cleus channels and their corresponding ipsilateral EEG channels, as
outlined previously (Halliday et al., 1995). The coherency between
two signals is a measure of their linear relationship at a specific fre-
quency. The definition of coherency and its statistical analysis is given
in the online supplementary material.
Only peaks with significant coherence values (Z4 1.96, P5 0.05)
in a bandwidth of five bins (1 Hz) in the theta-alpha band were
considered and their frequency and magnitude measured.
Neuroimaging: location of electrode
contacts
Preoperative (CT and MRI) and postoperative (MRI) images were
converted to the ANALYZE format and the SPM2 program was used
to co-register CT and MRI brain images from each patient pre- and
postoperatively. To determine the location of the electrode, all images
were processed with custom-designed software running under
MATLAB 7.7. The nine rods of the stereotactic frame visible by CT
were marked in order to orientate the images to the coordinates of
the stereotactic frame (Saw et al., 1987; Grunert, 1999; Li et al.,
1999). With respect to the mid-intercommissural point (anterior com-
missure–posterior commissure coordinates), the coordinates for each
individual patient were determined from the frame’s coordinates and
a point within the interhemispheric cerebral fissure in the preoperative
MRI, which define the mid-sagittal plane and its two orthogonal
planes. The anterior commissure–posterior commissure midpoint was
established as the origin of the anterior commissure–posterior commis-
sure coordinates. Any other data point for MRI was also situated into
the frame coordinates and transformed into the anterior commissure–
posterior commissure coordinates via a transformation matrix (Taub,
2000). More details are given in the supplementary material and
Supplementary Fig. 1.
Topographic analysis of local field
potentials
In order to study the distribution of the theta-alpha activity (4–10 Hz)
recorded in the subthalamic nucleus of patients with Parkinson’s
disease, we looked for phase reversals in contiguous channels of
the subthalamic nucleus recordings. The presence of a phase reversal
between two successive bipolar channels indicates that the activity
observed with opposite polarity in both channels may have its origin
around a common electrode (i.e. the activity with opposite polarity
in channels 0–1 and 1–2 is probably generated around contact 1).
Initially, the raw oscillatory activity around the theta-alpha peak
frequency was band-pass filtered, using a 2 Hz bandwidth linear
finite impulse response filter (2 Hz difference between the upper
and lower cut-off frequencies). The Hilbert transform was
then applied to calculate the phase time series associated with the
filtered signal. We then calculated the phase difference between
the adjacent channels recorded at each nucleus in order to detect
the contact where the phase reversal of activity was located. To
assess the statistical significance of the phase difference measure-
ments, a Rayleigh test of uniformity of angle was used (Valencia
et al., 2006). According to the asymptotic formula, the significance
of a value c ¼ ð1=NÞPNi¼1 eji





 determined from N segments
(each segment containing 45 cycles of the filtered signal) and
where i is the phase difference in each single segment, can be
calculated as eNc
2
.
The presence of a significant phase reversal (ideally a phase differ-
ence of 180 but which might vary depending on the angle of pene-
tration of the electrode with respect to the generator) between the
signal recorded in two adjacent contact pairs was used to locate the
probable origin of theta-alpha activity in each nucleus. In some nuclei
there was no phase reversal (the 3 channels were ‘in phase’) and in
such instances either the most ventral (0–1) or the most dorsal (2–3)
filtered channel had the highest amplitude (suggesting an origin at or
beyond the external contacts 0 or 3). The location of the phase re-
versals together with the contact coordinates obtained in the image
analysis allowed us to more accurately represent the topography of
low-frequency oscillatory activity in the subthalamic nucleus.
Statistics
Statistical analyses were carried out with Statistical Package for the
Social Sciences (SPSS) 15.0 software for Windows (SPSS Inc.,
Chicago, Illinois, USA) using the following tests:
(i) Clinical features: an ANOVA or a Kruskal–Wallis test (depending
on whether the variables were normally distributed) was used
to search for statistical differences between the clinical and
demographic features of the three groups of patients.
(ii) Oscillatory activity power analysis: the transformation to the
normal distribution described by van Albada and Robinson
(2007) was used to normalize the relative power values in the
ON to OFF motor states. Briefly, this transformation is based on
the fact that a uniform distribution can be obtained from any
continuous variable by computing its cumulative distribution
function. Thus the normalization of non-Gaussian variables
can be reached by the application of a function (inverse error
function) that transforms a uniform distribution to a normal
distribution. After normalization of the data, in each frequency
band, a three-way ANOVA was used to compare the mean
relative powers within the three different groups: Parkinson’s
disease-ICD, Parkinson’s disease-LID and Parkinson’s disease-
controls (Factor 1: group), in both subthalamic nuclei (Factor 2:
hemisphere) and at the three different contact pairs, dorsal (2–3),
intermediate (1–2) and ventral (0–1) (Factor 3: dorsoventral axis).
(iii) Oscillatory activity peak frequency analysis: in the ON state, the
frequency values of the spectral peaks in the theta-alpha band
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from the Parkinson’s disease-ICD and Parkinson’s disease-LID
groups were also normalized (van Albada et al., 2007). Three-
way ANOVA was then used to compare the differences in the
peak frequency in the two sub-groups (Parkinson’s disease-ICD
and Parkinson’s disease-LID), identifying peak activity at 6–10 Hz.
(iv) Cortico-subthalamic nucleus coherence analysis: subthalamic
nucleus-EEG links with significant coherence values were divided
into 12 groups depending on three factors, namely the groups of
patients (Parkinson’s disease-ICD, Parkinson’s disease-LID and
Parkinson’s disease-controls); the frequency of the coherence
peak (theta 4–7.5 Hz; alpha 7.5–10 Hz); and the cortical region
where the EEG electrode had been placed (motor: C3, C4 and
Cz, premotor-dorsolateral prefrontal cortex: F3 and F4). A con-
tingency table was prepared with the data grouped in this way
and the exact Fisher test was used to search for differences
between the conditions included in the design. Finally, we studied
the dorsoventral coordinates of the subthalamic nucleus pairs in
the boxes which showed significant deviations from expected
values.
Results
Twenty-eight patients with Parkinson’s disease were included in
the study; ten patients classified as Parkinson’s disease-ICD, nine
classified as Parkinson’s disease-LID and nine classified as
Parkinson’s disease-controls (having neither ICD nor dyskinesias,
refer to ‘Methods’ section for details). The general clinical charac-
teristics of the patients are summarized in Table 1 (for individual
details see Supplementary Table 1) and a summary of the behav-
ioural abnormalities of the Parkinson’s disease-ICD group is shown
in Table 2. There were no differences in age (F= 2.5, P= 0.1),
disease duration (F= 2.4, P= 0.12), UPDRS-III score in the
OFF (F= 0.3, P= 0.7) and ON (F= 3.7, P= 0.2) motor states,
L-dopa dose (F= 0.59, P= 0.56), treatment with dopamine agon-
ists (F= 0.86, P= 0.44) or L-dopa equivalent daily dose (F= 0.15,
P= 0.87) between the groups. Antipsychotic drugs and antidepres-
sants were not significantly different in the three groups of
patients (Fisher’s exact test P40.7 for all comparisons). There
were more male patients in the Parkinson’s disease-ICD group.
Recordings were obtained from 19 subthalamic nuclei in the 10
patients in the Parkinson’s disease-ICD group, 15 nuclei in the
nine patients in the Parkinson’s disease-LID group and 18 nuclei
in the nine patients in the Parkinson’s disease-control group. EEG
recordings were analysed from nine patients in the Parkinson’s
disease-ICD group, eight patients in the Parkinson’s disease-LID
group and nine patients in the Parkinson’s disease-control group.
Other subthalamic nucleus (four nuclei in four patients) and EEG
Table 2 Summary of the behavioural abnormalities in patients with Parkinson’s disease and ICD evaluated with the
Parkinson’s disease Impulse-Compulsive Questionnaire and the effect of the surgery
Patient Gambling Buying Sex Eating DDS Hobbying and punding Walkabout Effect of surgery
ICD1 + + +  +   Suppressed
ICD2 +     + (computers/play guitar)  Suppressed
ICD3 + +   +   Suppresseda
ICD4  + + + (binge eating
of sweets)
+ + (collecting watches) + Remaining walkabout
ICD5 +  + +  + (hunting)  Remaining hunting
and sex
ICD6   +  + + (writing novels and poetry,
computers, checking mail)
 Suppresseda
ICD7 + + +    Reduced severity
ICD8      + (Cleaning)  Suppressed
ICD9  +      Suppressed
ICD10     +   Not improved
DDS = Dopamine dysregulation syndrome.
a Mild abnormal impulsivity reappeared when dopaminergic treatment was transiently increased.
Table 1 General characteristics of the patients
Gender
(male)
Age
(years)
Disease
duration
(years)
UPDRS-III
OFF
UPDRS
ON
L-dopa/day
(mg)a
Dopamine
Agonist
(mg)b
Total L-dopa
equivalent
daily dose (mg)c
Parkinson’s disease-ICD (n= 10) 9 53.4 (11.4) 9.2 (3) 40.5 (12.5) 14.1 (5.9) 753.8 (606.3) 286.9 (297.3) 1040.7 (688.6)
Parkinson’s disease-LID (n= 9) 4 61.7 (4.2) 15.9 (11) 42.7 (10.7) 11.3 (6.4) 986.1 (503.4) 183.7 (142) 1169.8 (530.6)
Parkinson’s disease-Controls (n= 9) 6 58.7 (5.2) 10.8 (3.4) 38.1 (12.3) 9 (6.5) 745.2 (334.6) 278.5 (205.9) 1023.7 (464.9)
Values are stated as mean (SD).
a The L-dopa/day dose (mg) was calculated as follows: L-dopa (mg) + L-dopa retard (mg) 0.77. In case of entacapone/tolcapone co-administration the L-dopa dose was
multiplied by 1.33.
b Dopamine agonist = L-dopa equivalents of dopaminergic agonists. The formula used was: [rotigotine (mg)5] + [ropinirole (mg) 20] + [pramiprexole (mg) 67] +
[cabergoline (mg) 67] + [pergolide (mg) 100].
c Total L-dopa equivalent daily dose = dopaminergic agonists + L-dopa.
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recordings (one patient in the Parkinson’s disease-ICD group and
one in the Parkinson’s disease-LID group) were disregarded be-
cause of a low signal-to-noise ratio due to technical issues that
arose during recording.
Supplementary Fig. 2 shows the topographical distribution of
the different electrode contacts in the three groups of patients
along the dorsoventral axis. There was a small difference in
positioning between the LID group and the other two groups,
with the electrodes in patients with dyskinesia 0.7–1 mm more
dorsal (F= 8.182, P50.001). However, there was no difference
between the three groups in the coordinates of the contacts
used for stimulation (F= 0.94, P= 0.4).
Power spectrum of the oscillatory
activity
The OFF motor state showed a typical homogenous pattern in the
power spectrum analysis for the three groups of patients. Two
frequency peaks dominated the spectrum in the beta range, one
in the low-beta (12–20 Hz) and another in the high-beta range
(20–30 Hz: Fig. 1A and left side of Fig. 2).
Likewise, in the ON motor state, the gamma band (55–100 Hz)
was also similar for the three groups of patients. In the subthala-
mic nucleus of patients with Parkinson’s disease, a gamma activity
band has previously been associated with the ON state (Brown
et al., 2001; Lopez-Azca´rate, 2010), although an increase in the
gamma band is not always observed during the ON period
(Alonso-Frech et al., 2006). In this study, the gamma peak in
the ON state was only evident in a few patients (2 out of 10 in
the Parkinson’s disease-ICD group, 3 out of 9 in the Parkinson’s
disease-LID group and 2 out of 9 in the Parkinson’s
disease-controls group). Thus, no correlation between increased
gamma activity and LID or ICD could be established. By contrast,
changes in the theta-alpha range were detected in the ON motor
state that appeared to be specific to each clinical group of patients
with Parkinson’s disease.
Parkinson’s disease-impulse control disorders
In the ON state, a spectral peak appeared in the theta-alpha range
(Figs 1B and 2A, right) that had a mean peak frequency of
6.71 Hz (SD = 1.05 Hz; Fig. 3). The temporal evolution of the
power spectrum of the oscillatory activity in the (0–40 Hz) range
is illustrated in Fig. 2A for the most ventral contact pair (0–1) of a
representative patient (Patient PD-ICD-3) in both the OFF and
ON states. The attenuation in the low-beta band and the increase
in the theta-alpha band (5.8 Hz in this case) in the ON state is
clearly evident.
Parkinson’s disease L-dopa-induced dyskinesias
When dyskinesia was experienced in the ON state, a peak in the
spectrum was found in the theta-alpha range with a mean
frequency of 8.38 Hz (SD = 0.88 Hz; Fig. 1B). The frequency of
this peak was significantly higher than the frequency of the
peak found in the Parkinson’s disease-ICD group (Fig. 3). A re-
cording from the central contacts (pair 1–2) of the subthalamic
nucleus in a representative patient (Patient PD-LID-8) illustrates
the typical beta suppression and the appearance of a band of
activity at 7.5 Hz (Fig. 2B, right).
Parkinson’s disease-controls
The ON state of these patients was characterized by the typical
low beta attenuation alone (Fig. 1B). No theta-alpha band activity
was observed when the OFF and ON states of a typical patient
Figure 1 Mean power spectrum in the 0–45 Hz range (logarithmic scale) at all contact pairs in the three groups of patients [Parkinson’s
disease-ICD (PD-ICD), n= 19 nuclei; Parkinson’s disease-LID (PD-LID), n= 15 nuclei; Parkinson’s disease-controls (PD-Ctrls), n= 18
nuclei]. In the OFF state (A), the spectra of the three groups are similar, mainly characterized by the presence of two peaks in the beta
range (12–30 Hz). In the ON state (B), apart from the common decrease in the low-beta range, a theta peak (6.71 Hz) appears in the
Parkinson’s disease-ICD group and an alpha peak (8.38 Hz) in the Parkinson’s disease-LID group. No theta-alpha peak is present in the
Parkinson’s disease-control group.
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without ICD or LID were compared. It is shown for the central
contact pair (1–2) of a representative patient (Patient PD-Ctrl-5) in
Fig. 2C.
Statistical analysis of the power and
frequency of the alpha-theta peak
The changes in power from the OFF to ON motor state for
the different activity bands were assessed by three way
ANOVA. Since there was no relative power difference between
the groups for the beta band, the theta-alpha band was the only
activity band that behaved differently depending on the patient
group. The overall ANOVA revealed a significant effect of group
factor (Parkinson’s disease-ICD, Parkinson’s disease-LID or
Parkinson’s disease-controls: F= 61.69, P50.0001), while there
was no difference for the subthalamic nucleus in the right/left
hemispheres (F= 3.28, P= 0.072) nor for the dorsoventral axis
(F= 0.32, P= 0.73). Post hoc analysis revealed that both the
Parkinson’s disease-ICD and Parkinson’s disease-LID groups
presented a significantly higher relative power in the theta-alpha
range compared to the Parkinson’s disease-control group,
although there was no difference in power between patients
with Parkinson’s disease with LID and ICD.
When the differences in the theta-alpha peak frequency
between the Parkinson’s disease-ICD and Parkinson’s disease-LID
groups were assessed by three way ANOVA (the two groups that
showed a spectral peak in this frequency range), the theta-alpha
peak frequency was significantly higher in the Parkinson’s
disease-LID group than in the Parkinson’s disease-ICD group
(factor: group, F= 63.12; P5 0.0001; Fig. 3).
Topography of the theta-alpha activity
The intranuclear location of each contact pair in the dorsoventral
axis of the nucleus might differ among patients. Therefore we
Figure 2 Temporal evolution of the power spectrum in the 0–40 Hz range in both motor states during rest periods (OFF and ON).
(A) Patient PD-ICD-3 (left subthalamic nucleus, contacts 0–1). (B) Patient PD-LID-8 (left subthalamic nucleus, contacts 1–2). (C) PD-Ctrl-5
(right subthalamic nucleus, contacts 1–2).
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used the location of the phase reversal based on the postoperative
MRI analysis as a better topographical indicator of the origin of
the activity. The topographical distribution of theta-alpha band
was analysed in patients with Parkinson’s disease with ICD and
LID based on the localization of the electrode contacts where
this activity was generated according to the phase reversal
(Fig. 4). Accordingly, this activity was mainly generated in the ventral
contacts in the Parkinson’s disease-ICD group, while it was
found in the dorsal contacts in the Parkinson’s disease-LID group
(Fig. 5A). Indeed, the topography of this band differed in each
group (Fig. 5B) and while in the Parkinson’s disease-ICD group
the theta-alpha activity was generated in the ventral-intermediate
portion of the subthalamic area (from 2 to 8 mm from
the intercommissural line), this activity had a clear dorsal distribu-
tion in the Parkinson’s disease-LID group (from 0 to 2 mm from
the intercommissural line) (t-test for independent samples,
P5 0.0001).
Cortico-subthalamic coherence
(4–10 Hz band)
Coherence between the different subthalamic nucleus recording
channels and their corresponding ipsilateral EEG channels was stu-
died in the three groups of patients with Parkinson’s disease.
Significant coherence values in the theta-alpha range of the
EEG-subthalamic nucleus pairs were observed in the three
groups, although more commonly in the Parkinson’s disease-ICD
and Parkinson’s disease-LID groups. The subthalamic nucleus-EEG
pairs with significant coherence values in the theta-alpha band
(4–10 Hz) were grouped in a contingency matrix depending
on the clinical group (Parkinson’s disease-ICD, Parkinson’s
disease-LID and Parkinson’s disease-controls) and according to
the theta-alpha peak frequency that differed between the
Parkinson’s disease-ICD and Parkinson’s disease-LID groups.
Indeed, pairs with significant coherence values could be classified
depending on the peak frequency of coherence: theta 4–7.5 Hz
and alpha 7.5–10 Hz (Fig. 3, Table 3). Finally, the subthalamic
nucleus-EEG pairs could be grouped according to the position of
the EEG electrode in the pair (motor: C3, C4 and Cz, or premotor/
dorsolateral prefrontal cortex: F3 and F4).
From the contingency matrix with the observed and expected
number of significant pairs, a Fisher’s exact test revealed overall
significant differences between the groups (F= 15.664, P= 0.01;
Table 3). The data revealed more EEG-subthalamic nucleus pairs
with significant coherence in the 4–7.5 Hz range for the
Parkinson’s disease-ICD group than was expected, an increase
mainly found in the subthalamic nucleus-premotor/dorsolateral
prefrontal cortex-EEG pairs. By contrast, there were more signifi-
cantly coherent pairs than expected in the Parkinson’s disease-LID
group between the subthalamic nucleus and the motor cortex in
the 7.5–10 Hz band. The dorsoventral coordinates of the subtha-
lamic nucleus contacts in the Parkinson’s disease-ICD group that
were coherent at 4–7.5 Hz with frontal EEG channels (mean:
3.35 mm) were significantly more ventral than the coordinates
of the contacts in the Parkinson’s disease-LID group coherent with
central EEG leads at 7.5–10 Hz (mean: 1.88 mm; t=2.43,
P= 0.02).
Discussion
In this study, a specific oscillatory activity in the theta-alpha band
(4–7.5 Hz) with a peak at 6.71 Hz has been identified in patients
with ICD, indicating that the subthalamic nucleus is involved in
ICD induced by dopaminergic treatment in patients with
Parkinson’s disease. This activity was recorded 2–8 mm below
the intercommissural line, which includes the ventral, subthalamic
associative-limbic sub-region of the subthalamic nucleus.
Moreover, there is coherent activity between the subthalamic nu-
cleus and cortex, with the strongest subthalamic nucleus-EEG co-
herence present in the 4–7.5 Hz range and over skull electrodes
roughly corresponding to the premotor/dorsolateral prefrontal
cortex areas. These findings differ from the activity recorded in
the Parkinson’s disease-LID group that had a higher frequency
(mean 8.38 Hz, range 7.5–10 Hz). In addition, the peak activity
in the Parkinson’s disease-LID group was recorded from electrodes
located 0–2 mm below the intercommissural line compatible with
the dorsal motor region of the subthalamic nucleus, and subtha-
lamic nucleus-EEG coherence was found for electrodes close to
the primary motor and supplementary motor area cortices in the
7.5–10 Hz range. Accordingly, we believe that this theta-alpha
activity may serve as a physiological marker for ICD in
Parkinson’s disease, differing from that previously reported
for LID.
Figure 3 Boxplot of the theta-alpha peak frequency in both
Parkinson’s disease-ICD (PD-ICD) and Parkinson’s disease-LID
(PD-LID) groups. A peak at 6.71 Hz is observed in the
Parkinson’s disease-ICD group whereas a different peak at
8.38 Hz is present in the Parkinson’s disease-LID group.
*P5 0.001.
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Impulse control disorders and
theta-alpha oscillatory activity in
the subthalamic nucleus
Chronic dopaminergic treatment can induce motor and non-motor
side effects, mainly LID and ICD. Indeed, in recent years there has
been growing recognition of the incidence of ICD, probably
related to the increased use of dopamine agonists (Grosset
et al., 2006; Lu et al., 2006; Voon et al., 2006; Weintraub
et al., 2006; Evans and Butzkueven, 2007; McKeon et al., 2007;
Quickfall and Suchowersky, 2007; Tippmann-Peikert et al., 2007).
It has been well established that neuronal activity in the subtha-
lamic nucleus varies in Parkinson’s disease according to medication
state. Hence in the OFF state, the power of the beta band
(12–30 Hz) is largest, whereas in the ON motor state, the
gamma (60–100 Hz) band (Brown et al., 2001; Brown, 2003;
Gatev et al., 2006) predominates. However, in patients exhibiting
LID there is also 4–10 Hz oscillatory activity in the subthalamic
nucleus (Alonso-Frech et al., 2006). Despite the well-characterized
OFF/ON changes associated with motor fluctuations and dyskin-
esias, there is hitherto no physiological hallmark for ICD in patients
with Parkinson’s disease. We now demonstrate that L-dopa
induces specific, low frequency oscillatory activity in the theta-
alpha band (4–7.5 Hz), with a peak at 6.71 Hz in patients with
Parkinson’s disease and ICD.
The involvement of the subthalamic nucleus in non-motor, be-
havioural aspects related to impulsivity and disinhibition has been
documented in humans and animals. Lesion of the subthalamic
nucleus by infarction or tumour is associated with behavioural al-
terations characterized by agitation, manic states and logorrhoea,
Figure 4 (A) Filtered local field potentials from two patients in the ON motor state [Parkinson’s disease-ICD (PD-ICD) on the left and
Parkinson’s disease–LID (PD-LID) on the right] highlighting the phase reversal of the theta-alpha activity around contact 1 in the patient
from the Parkinson’s disease-ICD group and around contact 2 in the patient from the Parkinson’s disease-LID group. (B) Statistical analysis
of the phase difference (360 bins histogram, 300 s segment) from the same patients showing the phase reversal (peak in the histogram
near  radians) between contact pairs 1–2 and 0–1 in the patient from the Parkinson’s disease-ICD group (left). A phase reversal is also
shown for the patient in the Parkinson’s disease-LID group but between contact pairs 2–3 and 1–2 (right). The horizontal lines indicate the
mean phase difference in an ideally random distribution.
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with or without accompanying hemiballismus (Martin, 1927;
Trillet, 1995). More recently, deep brain stimulation of the sub-
thalamic nucleus in patients with Parkinson’s disease has been
associated with ICD and behavioural disinhibition (Krack et al.,
2001; Kulisevsky et al., 2002; Romito et al., 2002; Herzog
et al., 2003; Witt et al., 2004; Mandat et al., 2006; Frank
et al., 2007; Mallet et al., 2007; Doshi and Bhargava, 2008;
Raucher-Chene et al., 2008) and hyperactive behaviours have
been reported after lesion of the subthalamic nucleus in some
patients with Parkinson’s disease (i.e. disinhibition, hypomania,
excessive cheerfulness, talkativeness) (Alvarez et al., 2005). In
rats, subthalamic nucleus lesion increases the premature responses
during anticipation of a visual target in a five-choice serial reaction
time task and in other attention paradigms (Baunez and Robbins,
1997; Phillips and Brown, 2000), as well as increasing locomotor
activity conditioned to feeding (Baunez et al., 2002). Moreover,
subthalamic neurons in rats and monkeys modify their firing fre-
quency in response to reward related tasks, and in humans the
subthalamic nucleus region is activated during the performance of
an inhibition task (Aron and Poldrack, 2006; Li et al., 2008).
Together, these data indicate that the subthalamic nucleus also
participates in the control of non-motor events, such as impul-
sivity. The specific oscillatory activity identified here in the subtha-
lamic nucleus of patients with Parkinson’s disease and ICD is
consistent with the abundant clinical and experimental data
demonstrating that the subthalamic nucleus is not only a structure
involved in motor features of Parkinson’s disease, but also
engaged in behavioural control and ICD.
Topography of the low-theta activity
The 4–7.5 Hz activity in the Parkinson’s disease-ICD group was
mainly recorded from ventral contacts and it was coherent with
Figure 5 (A) Localization of the phase reversals for the different electrode contacts. In 12 out of 19 nuclei in the Parkinson’s disease-ICD
(PD-ICD) group, the theta-alpha activity was generated at the two most ventral contacts (0 and 1), while in 13 out of 15 nuclei in the
Parkinson’s disease-LID (PD-LID) group it was generated at the dorsal contacts (3 and 2). (B) Phase reversal contact coordinates in the
dorsoventral axis with respect to the intercommisural line, highlighting the different topography according to the patient classification.
STN = subthalamic nucleus.
Table 3 Contingency matrix with the observed and
expected number of significant coherent pairs in the theta
and alpha frequency ranges (4–7.5 Hz and 7.5–10 Hz)
between the subthalamic and the cortical EEG activity when
the leads are positioned overlying the primary motor/
supplementary motor areas (C3, C4, Cz) or the more
anterior premotor/dorsolateral prefrontal cortex areas
(F3, F4)
PD-ICD PD-LID PD-CTRL Row
totals
4–7.5 Hz – C3, C4, Cz Observed 4 1 4 9
Expected 3.2 3 2.8
4–7.5 Hz – F3, F4 Observed 8 0 1 9
Expected 3.2 3.0 2.8
7.5–10 Hz – C3, C4, Cz Observed 12 22 15 49
Expected 17.4 16.3 15.3
7.5–10 Hz – F3, F4 Observed 10 9 10 29
Expected 10.3 9.7 9.1
Column
Totals
34 32 30 96
PD-CTRL = Parkinson’s disease-controls; PD-ICD = Parkinson’s disease-ICD;
PD-LID = Parkinson’s disease-LID. Fisher’s exact test: F = 15.664, P = 0.01.
Bold boxes: cases in which the difference between the observed and the
expected values are significant.
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cortical activity recorded in premotor/dorsolateral prefrontal cortex
electrodes. By contrast, the activity in the Parkinson’s disease-LID
group (7.5–10 Hz) was recorded from the most dorsal subthalamic
nucleus contacts and it was coherent with central EEG scalp
electrodes (primary motor cortex/supplementary motor area).
The different topography of the oscillatory activity according
to the main dopaminergic complication (LID or ICD) depends on
the accuracy of the method used postoperatively to locate the
contacts of the electrode. We tried to minimize this shortcoming
by using image analysis to accurately determine the coordinates of
each contact. While some degree of error may still exist in calcu-
lating the coordinates of each contact implanted in the subthala-
mic nucleus, we believe that the relative position of the contacts
was sufficiently reliable to establish a definite correlation between
oscillatory activity and the recording sites in the dorsoventral axis.
Similarly, there may be concerns about the cortical area recorded
through the EEG contacts. The exact anatomical region corres-
ponding to each EEG electrode cannot be defined, although it is
generally accepted that the activity recorded through contacts C3,
C4 and Cz mainly originates in the primary motor cortex and
supplementary motor area, whereas the F3 and F4 electrodes cor-
respond to the premotor cortex and dorsolateral prefrontal cortex.
The different topography of the EEG-subthalamic nucleus coher-
ence at 4–7.5 Hz and 7.5–10 Hz in the cortex does fit with the
data available regarding impulse inhibition and LID. Functional
studies measuring regional cerebral blood flow with positron emis-
sion tomography have shown that the premotor cortex (among
other areas) is activated less in patients with Parkinson’s disease
with subthalamic nucleus stimulation who display reduced
response inhibition (Ballanger et al., 2009) and, during a task
requiring response inhibition, dorsolateral prefrontal cortex activa-
tion is also reduced (Thobois et al., 2007). By contrast, the motor
circuit (including the primary motor cortex and supplementary
motor area) is more strongly activated in patients with
Parkinson’s disease and LID than in patients not exhibiting this
complication (Rascol et al., 1998; Brooks et al., 2000). Thus, the
coherent activity at 4.5–7 Hz recorded in the more anterior frontal
areas appears to be specific and it contrasts with the dyskinetic
activity at 7.5–10 Hz found in primary motor and supplementary
motor area cortical regions.
These findings are perfectly compatible with the anatomo-
functional division of the subthalamic nucleus (Wichmann et al.,
1994; Parent and Hazrati, 1995; Lardeux et al., 2009) and with
observations suggesting that the ventral subthalamic nucleus is
involved in abnormal behaviour in Parkinson’s disease while the
dorsal subthalamic nucleus is related to motor aspects. Thus, ICD
or manic episodes can be induced by subthalamic nucleus stimu-
lation with a ventral contact of the electrode, an effect that is
reversed after switching off this contact. In contrast, stimulation
through more dorsal contacts (Kulisevsky et al., 2002; Mandat
et al., 2006; Mallet et al., 2007; Raucher-Chene et al., 2008)
usually provides maximum anti-parkinsonian benefit (Lanotte
et al., 2002; Starr et al., 2002) without behavioural side effects.
Moreover, dyskinesias can also be triggered by stimulation mainly
in the dorsal area of the subthalamic nucleus (Zheng et al., 2010)
There are also electrophysiological data supporting the involve-
ment of the ventral area in affective and cognitive matters
(Brucke et al., 2007). Neurons that modify their firing frequency
in response to reward tasks in the rat and monkey are located in
the medioventral half of the subthalamic nucleus (Matsumura
et al., 1992; Darbaky et al., 2005; Lardeux et al., 2009), in con-
trast to those responding to motor stimulus in the dorsal region
(Wichmann et al., 1994; Rodriguez-Oroz et al., 2001). Moreover,
local field potential recordings in patients with Parkinson’s disease
show that emotional stimulus led to a decrease in the alpha power
recorded mainly in the ventral subthalamic nucleus (Brucke et al.,
2007), whereas active movement led to a decrease in the beta
power recorded in the dorsal subthalamic nucleus (Alegre et al.,
2005). Indeed, subthalamic nucleus lesions in monkeys provoking
dyskinesias are located in the dorsal subthalamic nucleus while
those in the ventromedial region induce abnormal behaviour
(Crossman et al., 1984; Baron et al., 2002).
Relationship between dyskinesias and
impulse control disorders
In patients with Parkinson’s disease, both LID and ICD are asso-
ciated with specific changes in subthalamic nucleus oscillatory
activity in the alpha-theta band that differ in terms of peak
frequency and the territory where this activity is generated. We
previously described a 4–10 Hz oscillatory activity in the subthala-
mic nucleus (Alonso-Frech et al., 2006) associated with LID during
recording. This activity was not so clearly confined to the dorsal
region and in 45% of recordings the major change in the 4–10 Hz
band occurred at ventral sites. By contrast, we find here that
LID-related oscillations are by and large confined to the dorsal
portion of the subthalamic nucleus. This discrepancy may be
explained by a more detailed examination of the predominant
clinical features of the patients and their assessment in the present
work than in the earlier study (Alonso-Frech et al., 2006). At that
time, impulsivity was not well recognized as a clinical problem and
it was not a major reason for surgery. Hence, while this may have
been a clinical feature in some of these patients, it might not have
been sufficiently severe to be noted. In addition, an accurate
definition of the relative position of the contacts within the
electrode was not available at that time. Thus, the topography
of the recorded activity was not as precisely defined as in the
present report. It is also noteworthy that impulsive behaviour
disorders in patients with Parkinson’s disease often coincide with
LID (Silveira-Moriyama et al., 2006) and in patients with
Parkinson’s disease treated with bilateral subthalamic nucleus
lesions; choreic movements, as well as hyperactive and impulsive
behaviours, evolve together temporally, appearing and vanishing
in the same time-frame (Alvarez et al., 2005). In our patients,
the frequency of the oscillatory activity recorded overlaps in
both subgroups. Thus, the 4–10 Hz activity may be a relatively
general phenomenon associated with abnormal subthalamic
nucleus activity induced by dopaminergic treatment but mediated
by different circuits. Indeed, abnormal impulsivity may be seen
as part of a spectrum of basal ganglia disorders, embracing
motor, behavioural and emotional domains secondary to the
dysfunction of different anatomical territories (Mittal et al.; Voon
et al., 2009).
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Along with previous studies, our findings suggest that the sub-
thalamic nucleus has a general function in suppressing unwanted
or inadequate movements, actions and behaviours (DeLong, 1983;
Frank et al., 2007). We suggest that in Parkinson’s disease, dopa-
minergic overstimulation dampens this activity, liberating dyskin-
esias and misbehaviour through the oscillatory activity in the same
frequency band, but with different peaks expressed in different
functional areas of the subthalamic nucleus that correspond
to the different cortico-subcortical circuits. This idea is reinforced
by the fact that in patients with Parkinson’s disease and LID,
L-dopa treatment produces a higher dopamine concentration in
the dorsal striatum (de la Fuente-Fernandez et al., 2004), whereas
this effect is evident in the ventral striatum of patients with
Parkinson’s disease and ICD (Evans et al., 2006; Steeves et al.,
2009) where the dopamine transporter density is also lower (Cilia
et al., 2010). All these data indicate that the predominant motor
or behavioural side effects seen in patients with Parkinson’s
disease depend on the circuits in which dopaminergic activity
is greater (motor-dorsal or ventral-limbic), which in turns depends
on the extent of the underlying nigrostriatal or mesolimbic
denervation (Thobois et al., 2010).
Conclusion
In Parkinson’s disease, impulsivity disorders and dyskinesias
induced by dopaminergic treatment are differentially associated
with oscillatory activity in the theta-alpha band and are mediated
by the dysfunction of distinct anatomo-functional territories. This
is in keeping with current concepts about the basal ganglia,
whereby a common mechanism of action operates throughout
different domains (Jankowski et al., 2009). The differential en-
gagement and neuronal activity in subregions of the subthalamic
nucleus may have important implications for the selective target-
ing of the subthalamic nucleus or other basal ganglia nuclei as
deep brain stimulation expands to the treatment of neuropsychi-
atric disorders (Mallet et al., 2008). In addition, achieving better
modulation of the abnormal oscillatory activity should help obtain
the maximum benefit with the minimum undesirable side effects in
patients with Parkinson’s disease.
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